Results 181 to 190 of about 7,007,196 (291)

Persisting high rates of mental health disorders in patients in opioid agonist treatment-Results from a 6-year longitudinal study. [PDF]

Am J Addict
Soyka M, Koller G, Hans-Ulrich W, Bühringer G.   +3 more
europepmc   +1 more source

Substitution Patterns After Discontinuation of CNS‐Active Medications in Older Adults in Primary Care

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Little is known about substitution of alternative medications in the context of deprescribing. The objectives were to: (1) determine the frequency of medication substitutions among those who discontinued a central nervous system (CNS)‐active medication, and (2) characterize substitutions as potentially inappropriate (as per the 2023
Shelly L. Gray, Annalisa V. Piccorelli, Laura A. Hart, Andrea J. Cook, Brian D. Williamson, Benjamin H. Balderson, Elizabeth A. Phelan   +6 more
wiley   +1 more source

Treatment satisfaction among patients in opioid agonist treatment in Norway: A multicenter cohort study. [PDF]

Nordisk Alkohol Nark
Nesse L, Clausen T.
europepmc   +1 more source

Understanding Risks in the Care of People With Dementia in Acute Hospital Settings: Definitions, Types and Management Strategies—A Scoping Review

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aims This scoping review explores how risk is defined, managed and mitigated in the care of people with dementia in acute hospital settings. Methods This scoping review followed Arksesy and O'Malley's five‐stage framework (2005) and was guided by the Joanna Briggs Institute methodology.
Ashitha Bhaskaran, Kate Irving, Eileen Courtney, Bert Gordijn, Marie Cantwell   +4 more
wiley   +1 more source

National consensus statement on opioid agonist treatment in custodial settings. [PDF]

Med J Aust
Chan J, Cook J, Curtis M, Dunlop AJ, Morrison E, Nielsen S, Winter RJ, Naren T.   +7 more
europepmc   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

A feasibility study of a co-designed intervention to manage benzodiazepine dependence and high-risk use in those receiving opioid agonist treatment. [PDF]

Pilot Feasibility Stud
Matheson C, Berry K, Kilonzo M, Galea-Singer S, Hill D, Ritchie T, Schofield J, Stewart D, Turner M, MacLennan G.   +9 more
europepmc   +1 more source

Prescription of Psychotropic Drugs for Chronic Insomnia in Primary Care

Journal of Sleep Research, EarlyView.
ABSTRACT Insomnia is the most prevalent sleep disorder in adults, representing a major public health problem. Healthcare management in a specific area first requires analysing its current practices and issues. We conducted a retrospective observational study of over 100,000 patients from two large primary care databases in the public healthcare ...
Jesús Escribá‐Alepuz, Lidia Herrero‐Huertas, María García‐Gil, Estefanía Estévez‐López, Francisco Javier Puertas, Manuel de Entrambasaguas   +5 more
wiley   +1 more source

Veterinary Pharmaceutical Safety Competencies for New Graduates: Description of an Interprofessional Simulated Learning Activity

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT The misuse and abuse of veterinary anesthetic and analgesic agents pose significant public health risks, particularly with the growing presence of ultrapotent opioids and other anesthetics in the illicit drug trade. In response, there is increasing emphasis on incorporating medication safety training into veterinary curricula.
Margene Anderson, Carrie Schroeder, Kristopher M. Schroeder   +2 more
wiley   +1 more source

The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, Canada. [PDF]

Harm Reduct J
Jayathilake A, Hodgson K, Mansoor M, Markel K, Bardwell G.   +4 more
europepmc   +1 more source